Answers are grounded in this paper and cite their sources.
Thalidomide is often used for the management of refractory gastrointestinal angiodysplasia (GIAD). The tolerance, toxic profile, and compliance of thalidomide are dose-dependent. The low-dose thalidomide (50 mg) is safe and a viable option for bleeding related to GIAD.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: